Anti-Human Human VEGFR2 (Ramucirumab Biosimilar)
Catalog #500050
| Cat # | Size | Price | Quantity | |
|---|---|---|---|---|
| 500050 | 1 mg | $200.00 | ||
| 500050 | 5 mg | $600.00 | ||
| 500050 | 20 mg | $1,250.00 |
Product Details
Ramucirumab biosimilar is a recombinant human monoclonal antibody targeting vascular endothelial growth factor receptor 2 (VEGFR2). It is widely used in research related to angiogenesis, cancer, and ocular disorders. This biosimilar retains the same variable region sequence as therapeutic Ramucirumab and is primarily applied in ELISA, flow cytometry, and functional assays.
Specifications
| Clone | Ramucirumab |
|---|---|
| Reactivities | Human |
| Isotype | Human IgG1 |
| Recommended Isotype Control | Human IgG1 isotype control |
| Format | Liquid |
| Formluation | PBS, pH 6.0 |
| Sterility | 0.2 µm filtered |
| Clonality | Recombinant |
| Conjugation | Unconjugated |
| Immunogen | Human VEGFR2 |
| Host | CHO cells |
| Purity | >95% (HPLC, SDS-PAGE) |
| Endotoxin | < 1.0 EU/mg (LAL assay) |
| Grade | In vivo ready (RUO) |
| Application | Neutralization; Flow Cytometry; ELISA; WB |
| Purification | Protein A |
| Storage Conditions | 2-8 °C, Avoid freeze / thaw cycle |
| Shelf Life | 6 months |
| Regulatory Status | RUO |